We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UCB Files Flurry of Patent Infringement Suits Over Vimpat
UCB Files Flurry of Patent Infringement Suits Over Vimpat
July 19, 2013
Germany’s UCB filed a whopping 15 patent infringement suits July 10 in a Delaware court to stave off generic drugmakers Sandoz, Glenmark, Watson and a dozen more from entering the market with copycats of its epilepsy treatment Vimpat, which loses marketing exclusivity in October.